Health Condition 1: M545- Low back pain
Conditions
Interventions
Intervention1: Individualized homoeopathic medicines in LM potencies plus concomitant care: The enrolled patients of chronic low back pain will be treated with individual homoeopathic medicines (IHMs)
dosage and repetition depending upon the individual recruitment of the cases. Patients will be advised to refrain from handling the bottle or from eating, drinking, smoking or brushing teeth within 30
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age group 18-65 years 2. Participants of either sex or transgender 3. Patients suffering from low back pain for 3months or more 4. Patients suffering from moderate and severe pain; using Numeric Rating Scale (NRS).Patients will be categorized into mild (NRS 0-3), moderate (NRS 4-7) or severe (NRS 8-10). 5. Patients with radiological diagnosis indicating different causes of low back pain, mild to moderate degenerative radiological changes.
Exclusion criteria
Exclusion criteria: 1. Unwilling to take part and not providing with written informed consent of participation. 2. Patients who have undergone spine surgery within 6 months. 3. Patients with severe degenerative changes in radiological findings like congenital abnormalities, infection, tumour, malignancy. 4. Patients having severe and extremely severe DASS-21 score (severe depression-11-13, anxiety-8-9, stress-13-16 and extremely severe depression-14+, anxiety -10+, stress-17+) 5. Immuno-compromised state, AIDS, hepatitis et 6. Uncontrolled diabetes, hypertension, cancer or any other systemic illness or any vital organ failure. 7. Vulnerable population: unconscious,non-ambulatory,too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent people. 8. Tobacco chewing and/ or smoking, alcoholism and/ or any form(s) of substance abuse and/ or dependance (TAPS tool) 9. Pregnancy, puerperal women and lactating mother. 10. Undergoing homoeopathic treatment for any chronic disease within last 6months. 11. Simultaneous participation in any other clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To explore feasibility of a definitive future trialTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Oswestry Disability Index (ODI)Timepoint: Baseline, every month, up to 3 months;Depression, Anxiety, Stress Scale Short Form (DASS-21)Timepoint: Baseline, every month, up to 3 months | — |
Countries
India
Contacts
Public ContactSubhasish Ganguly
D N De Homoeopathic Medical College and Hospital
Outcome results
None listed